Circulating vitamin D level before initiating chemotherapy impacts on the time-to-outcome in metastatic colorectal cancer patients: systematic review and meta-analysis
Alessandro Ottaiano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Massimiliano Berretta(University of Messina), Maria Lucia Iacovino(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Francesco Perri(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Mariachiara Santorsola(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Vincenzo Quagliariello(Cancer Institute (WIA)), Guglielmo Nasti, Nicola Maurea(Cancer Institute (WIA)), Domenico Iervolino(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Andrea Ronchi(University of Campania "Luigi Vanvitelli"), Sergio Facchini(Ospedale Santa Maria), Bianca Arianna Facchini(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alessia Bignucolo(University of Messina)
Cited by 12
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience
|Cancer Biology & Therapy|2010|108
Resveratrol in Cancer Patients: From Bench to Bedside
|International Journal of Molecular Sciences|2020|105
Ranolazine Protects from Doxorubicin-Induced Oxidative Stress and Cardiac Dysfunction
|European Journal of Heart Failure|2014|92